Hematology
Glenn Hanna, M.D.
Director of the Center for Cancer Therapeutic Innovation (CCTI), the early drug development program at DFCI. His clinical and translational research eff
Dr. Hanna completed his fellowship training in hematology and medical oncology at Dana-Farber Cancer Institute in 2016. Prior to this, he earned his medical degree from Georgetown University School of Medicine in 2010, where he graduated summa cum laude, a member of Alpha Omega Alpha Honor Society and the Kober Medalist for academic excellence. He joined the faculty of the Center for Head and Neck Oncology in 2017. Dr. Hanna is the Director of the Center for Cancer Therapeutic Innovation (CCTI),
16+
Years in Practice
Credentials
Board Certifications
- Internal Medicine, 2014
- Medical Oncology, 2016
Education & Training
- Georgetown University School of Medicine (MD)
- Beth Israel Deaconess Medical Center, Internal Medicine (Residency)
- Dana-Farber/Partners CancerCare, Hematology/Oncology (Fellowship)
Peer Recognition
- Castle Connolly — Top Doctor
2022-2026 (5 years)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
- Dana-Farber/Brigham and Women's Cancer Center
Experience
16+ years in practice